Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Page 1
Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations.
de Pádua Serafim A, Saffi F, Soares ARA, Morita AM, Assed MM, de Toledo S, Rocca CCA, Durães RSS. de Pádua Serafim A, et al. Among authors: morita am. BMC Psychol. 2024 Apr 26;12(1):236. doi: 10.1186/s40359-024-01740-7. BMC Psychol. 2024. PMID: 38671529 Free PMC article.
CONCLUSIONS: Our findings provide empirical evidence regarding the long-term cognitive effects of COVID-19, particularly in individuals experiencing severe manifestations of the disease. ...
CONCLUSIONS: Our findings provide empirical evidence regarding the long-term cognitive effects of COVID-19, particularly in individua …
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: Results from a randomised, double-blind, placebo-controlled, phase II/III clinical study in patients aged ≥13 years.
Yokozeki H, Murota H, Matsumura T, Komazaki H; Nemolizumab-JP11 Study Group. Yokozeki H, et al. Br J Dermatol. 2024 Apr 17:ljae131. doi: 10.1093/bjd/ljae131. Online ahead of print. Br J Dermatol. 2024. PMID: 38629497
OBJECTIVES: To evaluate the optimal dose, efficacy, and safety of long-term treatment with nemolizumab in patients with prurigo nodularis in Japan. ...
OBJECTIVES: To evaluate the optimal dose, efficacy, and safety of long-term treatment with nemolizumab in patients with prurigo nodul …
Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database.
Tada Y, Guan J, Iwasaki R, Morita A. Tada Y, et al. Among authors: morita a. J Dermatol. 2024 Mar;51(3):391-402. doi: 10.1111/1346-8138.17097. Epub 2024 Jan 12. J Dermatol. 2024. PMID: 38214545
Treatment patterns varied considerably, highlighting the need for treatment algorithms and effective, well-tolerated medications to support patients to help them remain on long-term therapy....
Treatment patterns varied considerably, highlighting the need for treatment algorithms and effective, well-tolerated medications to support …
Pediatric psoriasis: Understanding pathological conditions and advances in treatment.
Morita A, Saeki H. Morita A, et al. J Dermatol. 2024 Feb;51(2):185-195. doi: 10.1111/1346-8138.17049. Epub 2023 Dec 17. J Dermatol. 2024. PMID: 38105636 Review.
In addition, psoriasis is often associated with various comorbidities that may place a great burden on the physical and mental health of the children beyond those due to psoriasis itself. To ensure good long-term health outcomes, individuals with psoriasis should undergo r …
In addition, psoriasis is often associated with various comorbidities that may place a great burden on the physical and mental health of the …
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review.
Tada Y, Komine M, Okubo Y, Habiro K, Tsuritani K, Morita A. Tada Y, et al. Among authors: morita a. J Dermatol. 2024 Feb;51(2):210-222. doi: 10.1111/1346-8138.17038. Epub 2023 Nov 30. J Dermatol. 2024. PMID: 38031882
This retrospective medical chart review allowed us to understand the real-world, long-term treatment patterns of systemic drugs for PsO and the relationships between the reasons for treatment changes and subsequent treatment selection, indicating that there is still room f …
This retrospective medical chart review allowed us to understand the real-world, long-term treatment patterns of systemic drugs for P …
Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations.
Nakagawara K, Morita A, Namkoong H, Terai H, Chubachi S, Asakura T, Tanaka H, Ito F, Matsuyama E, Kaji M, Saito A, Takaoka H, Okada M, Sunata K, Watase M, Yagi K, Ohgino K, Miyata J, Kamata H, Kawada I, Kobayashi K, Hirano T, Inoue T, Kagyo J, Shiomi T, Otsuka K, Miyao N, Odani T, Baba R, Arai D, Nakachi I, Ueda S, Funatsu Y, Koh H, Ishioka K, Takahashi S, Nakamura M, Sato T, Hasegawa N, Kitagawa Y, Kanai T, Ishii M, Fukunaga K. Nakagawara K, et al. Among authors: morita a. Vaccine X. 2023 Sep 1;15:100381. doi: 10.1016/j.jvacx.2023.100381. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37731516 Free PMC article.
We conducted a subgroup analysis of a study on the long-term effects of COVID-19 (long COVID) in Japan to assess the effect of vaccination on long COVID symptoms. ...
We conducted a subgroup analysis of a study on the long-term effects of COVID-19 (long COVID) in Japan to assess the effect of vaccin …
Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies.
Takeuchi T, Nishikawa K, Yamada F, Morita A, Ohtsuki M, Suzuki Y, Watanabe M, Yamanaka H, Hibi T. Takeuchi T, et al. Among authors: morita a. Drug Saf. 2023 Oct;46(10):991-1005. doi: 10.1007/s40264-023-01340-1. Epub 2023 Sep 12. Drug Saf. 2023. PMID: 37700154 Free PMC article.
OBJECTIVE: We performed an integrated analysis of final data from three post-marketing studies to provide long-term safety and efficacy data of CT-P13 in a real-world clinical setting. ...With CT-P13 therapy, disease activity parameters decreased similarly in all four dise …
OBJECTIVE: We performed an integrated analysis of final data from three post-marketing studies to provide long-term safety and effica …
Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY).
Tada Y, Morita A, Yamanaka K, Kono M, Imafuku S, Okubo Y, Yamazaki F, Kawamura T, Itakura A, Ohtsuki M. Tada Y, et al. Among authors: morita a. J Dermatol. 2023 Nov;50(11):1415-1426. doi: 10.1111/1346-8138.16926. Epub 2023 Aug 24. J Dermatol. 2023. PMID: 37615243
Secukinumab, the first interleukin 17A inhibitor, has been used for the systemic treatment of psoriasis, but its long-term, real-world retention rates in Japan have not been fully investigated. ...
Secukinumab, the first interleukin 17A inhibitor, has been used for the systemic treatment of psoriasis, but its long-term, real-worl …
Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study.
Morita A, Yagi K, Asakura T, Namkoong H, Sato Y, Ogawa T, Kusumoto T, Suzuki S, Tanaka H, Lee H, Okamori S, Azekawa S, Nakagawara K, Kaji M, Nagao G, Funatsu Y, Kimizuka Y, Kamata H, Nishimura T, Ishii M, Fukunaga K, Hasegawa N. Morita A, et al. BMC Pulm Med. 2023 Jul 6;23(1):247. doi: 10.1186/s12890-023-02528-y. BMC Pulm Med. 2023. PMID: 37415094 Free PMC article.
BACKGROUND: The long-term exercise tolerance changes in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) are of great interest because of its chronic course. ...
BACKGROUND: The long-term exercise tolerance changes in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) are of …
Time sharing in working memory processing.
Barrouillet P, Camos V, Minamoto T, Nishiyama S, Chooi WT, Morita A, Logie RH, Saito S. Barrouillet P, et al. Among authors: morita a. J Exp Psychol Learn Mem Cogn. 2023 Oct;49(10):1539-1556. doi: 10.1037/xlm0001261. Epub 2023 Jun 12. J Exp Psychol Learn Mem Cogn. 2023. PMID: 37307321
Although working memory (WM) is usually defined as a cognitive system coordinating processing and storage in the short term, in most WM models, memory aspects have been developed more fully than processing systems, and many studies of WM tasks have tended to focus on memor …
Although working memory (WM) is usually defined as a cognitive system coordinating processing and storage in the short term, in most …
87 results